-
Masdar Completes $950M Lockhart Solar and Storage Project in California
-
USMNT Coaching Search: Guardiola, Cherundolo, and Others Named as Pochettino Replacements
-
Mansa’s AI Microdrama Sparks Debate Over Black Representation in Hollywood
-
SDF Intelligence Unit Avoided Classifying Civilian Data as Public Records
-
Microsoft Outage Disrupts Outlook and Teams for Hours Globally
-
Inflation Breach and Bond Yields Spark Rate Hike Fears for December
-
RSC’s ‘Julius Caesar’ Reimagined in Women’s Prison Setting for School Tour
-
Documentary Reveals How Screams Exposed Alleged Camgirl Exploitation Ring
-
Korea Reviews GLP-1 Vision Loss Warnings Following US FDA Action
-
Xenetic Biosciences Reports Third Quarter 2026 Financial Results and Highlights Strategic Business Updates
-
Arrive AI Reports Third Quarter 2026 Results Highlighted by Revenue Growth and Expanded Partnerships
-
Does IRS Debt Expire? Clear Start Tax Explains the 10-Year Collection Statute and What Quietly Resets It
-
GameSquare's Hatchet Publishes TikTok Live for Gaming in H1 2026 Report
-
Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q2
-
Mako Mining Reports Q3 2026 Financial Results, Including Adjusted EBITDA(1) of US$30.3 million and EPS of US$0.19/share
-
eXoZymes to Host Third Quarter 2026 update Conference Call on Thursday, November 19, 2026
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 13
-
How Families Plan and Save for Holiday Travel
-
Greenwich LifeSciences Interview to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
-
ACCESS Newswire Continues to Repurchase its Shares
-
Road Access Completed Drill Program to Begin
-
SMX Brings American Ingenuity to the Next Frontier of Artificial Intelligence
-
Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
-
The Epomaker Alice40 Brings Mahjong Sound and Sunset Style to Ergonomic Typing
-
MARS Energy Group Adds Jigar Shah to Advisory Board to Accelerate Battery Storage Growth
-
DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update
-
Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates
-
Below Deck alumnus João Franco and brother arrested after fatal Turkey fight
-
Ole Miss inquiry expands after video and monkey-noise allegations
-
General Hospital actor Randall England dies at 75
-
Argentina Inflation Rises to 2.2% in October Amid Core Price Decline
-
Bunnie XO artwork taken down from Jelly Roll’s Nashville bar
-
London museum removes Russell Brand hair exhibit after rape conviction
-
NRC Approves Construction of Advanced Nuclear Reactors at Texas Petrochemical Site
-
Arlington sentinel rebukes Pete Hegseth entourage for laughter near memorial
-
Yella Beezy sentenced to life for arranging rapper Mo3’s murder
-
Kylie Jenner employee describes closet ordeal and pepper-spray incident
-
Xi Jinping Urges Unity and Reunification at Sun Yat-sen Anniversary
-
Raz B's Son Died of Asphyxia Due to Airway Obstruction
-
Toddler Diagnosed With Leukemia After Symptoms Dismissed as Winter Illness
-
Authorities to identify Montauk Mary and five other Long Island cold-case victims
-
Davante Adams injury deepens Los Angeles Rams receiver shortage
-
Barbie sequel negotiations stall over reported $25 million pay packages
Embiid to miss rest of NBA season with knee injury - 76ers
Philadelphia's star center Joel Embiid will miss the rest of the NBA regular season as he and the team continue to seek a solution for the left knee trouble that has hindered him this season, the 76ers said on Friday.
The Cameroon-born big man, who was the NBA Most Valuable Player in 2023, has missed numerous games this season because of pain and swelling in the knee, and told reporters last week that the injury didn't allow him to play to his highest standard.
"The Philadelphia 76ers and Joel Embiid have been consulting with top specialists regarding ongoing issues with his left knee," the team said in a statement on Friday.
"After further evaluation, it has been determined that he is medically unable to play and will miss the remainder of the season to focus on treatment and rehabilitation."
Embiid has played just 19 games this season.
He was limited to 39 games last season after tearing the meniscus in his knee. He had surgery in February 2024 and returned in April for the 76ers' playoff run.
He went on to win an Olympic gold medal with the United States in Paris, and this month acknowledged that he didn't have adequate time after his surgery to recover.
"The way I was playing a year ago is not the way I'm playing right now," Embiid said this month.
"It sucks. I probably need to fix the problem, and then I'll be back at that level. But it's hard to have trust when you're not yourself," added Embiid, who averaged 23.8 points and 8.2 rebounds this season.
Embiid, who missed the first nine games of the season between knee problems and a suspension, then ran into injury trouble with knee pain and a sprained foot.
He also suffered a sinus fracture.
After Embiid sat out all of the fourth quarter of the Sixers' loss to the Brooklyn Nets on February 22, ESPN reported that he and the team had decided to consult doctors to explore "alternative options" after treatments including injections used this season were ineffective.
"He's giving us what he can," 76ers coach Nick Nurse said last week. "He's not certainly the guy we're used to seeing play at a super-high level. I commend him for giving us what he can."
A.O.Scott--AT